BioCardia(BCDA) - 2024 Q3 - Quarterly Results

Exhibit 99.1 BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results Sunnyvale, Calif. – November 13, 2024 - BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the third quarter of 2024 and filed its quarterly report on Form 10-Q for the three and nine months ended September 30, 2024 with the Securities and Exchange Commission. The Company will also hold ...